Multiple Sclerosis Treatment in Kathmandu — Disease-Modifying Therapy and Management

Multiple sclerosis (MS) treatment has evolved significantly in recent years. The primary goal is reducing relapse frequency and slowing disability progression through disease-modifying therapies (DMTs). At Kathmandu Neurology Clinic & Cognitive Center, Dr. Jitendra Prasad Yadav (NMC 8029) provides comprehensive MS management tailored to disease type, severity, and individual patient factors.

Disease-modifying therapies work by modulating the immune system to reduce inflammation and demyelination. Options include injectable therapies (interferon beta, glatiramer acetate), oral medications (fingolimod, dimethyl fumarate, teriflunomide), and monoclonal antibodies (ocrelizumab, natalizumab). The choice depends on disease activity, relapse rate, MRI findings, and factors such as pregnancy planning and infection risk. High-efficacy therapies are typically recommended for highly active MS or rapidly evolving severe relapsing-remitting MS.

Dr. Jitendra Prasad Yadav — consultant neurologist & headache specialist at Kathmandu Neurology Clinic & Cognitive Center provides evidence-based evaluation for multiple sclerosis.

Symptom management addresses specific MS-related problems. Spasticity may be treated with baclofen, tizanidine, or botulinum toxin injections. Fatigue management includes energy conservation strategies, amantadine, and addressing sleep disorders. Neuropathic pain responds to gabapentin, pregabalin, or duloxetine. Bladder dysfunction may require anticholinergics and behavioural strategies. Depression and anxiety are common and should be screened for and treated.

Rehabilitation and lifestyle are equally important. Physiotherapy maintains mobility and prevents contractures. Occupational therapy helps with daily activities and adaptive equipment. Regular exercise, vitamin D supplementation, smoking cessation, and stress management all contribute to better outcomes.

Regular monitoring with clinical assessment and MRI brain (typically annually) tracks disease activity and treatment response. DMT adjustments are made based on breakthrough relapses, new MRI lesions, or treatment intolerance.

See /multiple-sclerosis-doctor-kathmandu for detailed evaluation. This article is educational and does not replace individual medical advice.

**Frequently Asked Questions**

Q: Is multiple sclerosis curable? A: Currently, there is no cure for MS, but disease-modifying therapies can significantly reduce relapse frequency and slow disability progression. Many people with MS live full, productive lives with appropriate treatment and lifestyle management.

Q: What are the first symptoms of multiple sclerosis? A: Common first symptoms include visual changes (optic neuritis), numbness or tingling in limbs, weakness, balance problems, and fatigue. Symptoms vary depending on which part of the central nervous system is affected.

Q: How is multiple sclerosis diagnosed? A: MS diagnosis requires demonstrating dissemination in time and space using the McDonald criteria. This typically involves MRI brain and spinal cord, clinical history of relapses, and sometimes cerebrospinal fluid analysis. No single test confirms MS.

Q: Can pregnancy affect multiple sclerosis? A: Pregnancy generally reduces MS relapse frequency, particularly in the third trimester. Relapse risk increases in the postpartum period. Many DMTs must be stopped before conception, and treatment decisions require careful planning with neurology and obstetrics.

Q: What lifestyle changes help with multiple sclerosis? A: Regular exercise, vitamin D supplementation, smoking cessation, stress management, and a Mediterranean-style diet are all associated with better outcomes. Adequate sleep and avoiding excessive heat are also important.

Q: How often should MRI be done for multiple sclerosis? A: For patients on stable treatment, annual MRI is common to monitor for new lesions. MRI frequency may be higher during diagnostic evaluation, after treatment changes, or if clinical worsening occurs.